Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Kewaunee Scientific (KEQU) over the last 15 years, with Q4 2025 value amounting to $189.1 million.

  • Kewaunee Scientific's Liabilities and Shareholders Equity rose 4059.92% to $189.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $766.4 million, marking a year-over-year increase of 4526.36%. This contributed to the annual value of $194.7 million for FY2025, which is 4443.85% up from last year.
  • Per Kewaunee Scientific's latest filing, its Liabilities and Shareholders Equity stood at $189.1 million for Q4 2025, which was up 4059.92% from $193.5 million recorded in Q3 2025.
  • In the past 5 years, Kewaunee Scientific's Liabilities and Shareholders Equity ranged from a high of $194.7 million in Q2 2025 and a low of $89.4 million during Q2 2021
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $123.3 million (2023), whereas its average is $130.2 million.
  • In the last 5 years, Kewaunee Scientific's Liabilities and Shareholders Equity tumbled by 65.66% in 2023 and then surged by 4975.5% in 2025.
  • Over the past 5 years, Kewaunee Scientific's Liabilities and Shareholders Equity (Quarter) stood at $94.3 million in 2021, then rose by 26.33% to $119.1 million in 2022, then increased by 2.17% to $121.7 million in 2023, then grew by 10.49% to $134.5 million in 2024, then soared by 40.6% to $189.1 million in 2025.
  • Its last three reported values are $189.1 million in Q4 2025, $193.5 million for Q3 2025, and $194.7 million during Q2 2025.